Back to GetFilings.com




U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 10-QSB


[x] Quarterly Report under Section 13 or 15(d) of the Securities Exchange Act of 1934
 
 For the quarterly period ended  December 31, 2004                        

[ ] Transition Report under Section 13 or 15(d) of the Exchange Act For the Transition Period from ________ to ___________


Commission File Number: 000-30646                    


Industrial Enterprises of America, Inc.
(formerly known as Advanced Bio/Chem, Inc.)
(Exact name of registrant as specified in its charter)



   Nevada  13-3963499
  (State or jurisdiction of incorporation (I.R.S. Employer Identification No.)
   or organization)  
     
   770 South Post Oak Lane, Suite 330  Houston, Texas 77056 
   (Address of principal executive offices)  (Zip Code)
     
   (Registrant’s telephone number, including area code)  (713) 622-2875
 

 
Advanced Bio/Chem, Inc., December 31
(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes [ ] No [X]

APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
PROCEEDING DURING THE PRECEDING FIVE YEARS

Check whether the registrant filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act after the distribution of securities under a plan confirmed by a court. Yes [ ] No [ ]

APPLICABLE ONLY TO CORPORATE ISSUERS

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.

As of March 30, 2005, 27,624,190 shares of the registrant’s Common Stock were outstanding.


Transitional Small Business Disclosure Format (Check one): Yes [ ] No [x]







Table of Contents


 
Page
 
Recent Developments……………………………………………………….
 
1
 
 
Part I
 
Item 1. Financial Statements….……………………………………………..
2
Item 2. Management’s Discussion and Analysis or Plan of Operations ……
3
Item 3. Controls and Procedures…...………………………………………..
7
 
 
Part II
 
Item 1. Legal Proceedings..…………………………..………………………
7
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds ………
8
Item 3. Defaults Upon Senior Securities……………………………………..
8
Item 4. Submission of Matters to a Vote of Security Holders ………………
8
Item 5. Other Information……………………………………………………
8
Item 6. Exhibits………………………...……………………………………..
8
 
 
 
 







Recent Developments

Change in Fiscal Year End

On December 22, 2004, the Board of Directors of Industrial Enterprises of America, Inc., a Nevada corporation (the “Company”), approved the change in the Company’s fiscal year end from December 31 to June 30. The Company, as the parent of EMC Packaging, Inc., a Delaware corporation (“EMC”), is now a holding company of an operating subsidiary. The fiscal year end of EMC is June 30; therefore, in order to more closely align its operations and internal controls with that of its wholly owned subsidiary, the Board of Directors approved the change in the Company’s fiscal year end. The change is described in further detail in the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission (the “Commission”) on March 30, 2005.
1
 

 
Item 1.  Financial Statements

 
Critical Accounting Policies

The Company believes that the following critical accounting policies reflect its more significant judgments and estimates used in the preparation of its consolidated financial statements:

The following significant accounting policies pertain to EMC Packing, Inc.(“EMC”), the Company’s current sole operating unit at December 31, 2004.

Revenue Recognition 

EMC is primarily engaged in the manufacturing and sale of packaged refrigerants for the automotive and dusting markets. Revenue is recognized with the successful manufacture and delivery of such product to the end user customer.

Inventory

Inventory is stated at the lower of cost or market, with cost determined on a first-in, first-out basis.

Machinery and Equipment

Machinery and equipment are recorded at cost. Depreciation is computed on the estimated useful lives of the assets ranging from three to ten years using the straight-line method.

Income Tax

The Company recognizes deferred tax assets and liabilities based on differences between the financial reporting and tax bases of assets and liabilities using the enacted tax rates and laws that are expected to be in effect when the differences are expected to be recovered. The Company provides a valuation allowance for deferred tax assets for which it does not consider realization of such assets to be more likely than not. Management has determined as of December 31, 2004 that it is not probable that the Company will realize a future tax benefit from its deferred tax assets.

Accounting for Stock-Based Compensation

The Company has adopted the disclosure provisions of SFAS No. 123, “Accounting for Stock-Based Compensation.” In accordance with the provisions of SFAS No. 123, the Company applies Accounting Principles Board Opinion 25 and related interpretations in accounting for stock issued to its employees and consultants. Management exercises judgment in its determination of when significant non-cash stock transactions have occurred.

Please see the Financial Statements beginning on page F-1.

2



Item 2. Management’s Discussion and Analysis or Plan of Operations.

Acquisition of EMC Packaging, Inc.

As previously disclosed, on October 7, 2004, the Company’s Board of Directors approved the purchase of all of the issued and outstanding capital stock of EMC, which had been in business since 1974. On the effective date of the purchase, EMC became the Company’s wholly owned subsidiary. In consideration for their shares of EMC common stock, the EMC stockholders received an aggregate of 2,296,800 shares of the Company’s common stock, valued at $808,474. The Company, as the new parent company of EMC and through EMC, intends to continue to market and sell the products that had been offered by EMC prior to the acquisition.

The calculation of cost in excess of net assets acquired is as follows:


 
 Purchase price of EMC  
 $      808,474
 Less assets acquired  
 (1,730,325)
 Add liabilities assumed  
 1,339,880
 Cost in excess of net assets acquired  
 $      418,029
 
The cost in excess of net assets acquired has been recorded as goodwill on the Company’s financials.

The following is a summary of the operating results of EMC since acquisition that has been included in the Company’s three and six months ended December 31, 2004 statement of operations in this quarterly report on Form 10-QSB:


     
EMC
 
     
From Oct 7 to
 
     
December 31, 2004
 
Net sales
 
$ 1,348,787
 
Cost of goods sold
 
1,126,505
 
 
Gross profit
 
$ 222,282
 
Selling and administrative expenses
 
$ 11,488
 
Salaries and contract labor
 
146,028
 
Depreciation and amortization
 
5,971
 
Legal and professional
 
42,781
 
 
Total expenses
 
$ 206,268
 
Net (loss) from operations
 
$ 16,014
 
Interest expense
 
$ 43,286
 
 
Income before income taxes
 
 
 
 
and discontinued operations
 
$ (27,272)
 
Gain on discontinued operations
 
$ -
 
 
Income(Loss) before income taxes
 
$ (27,272)
 
Income tax (benefit) expense
 
$ (9,338)
 
 
Net income
 
$ (17,934)
 



3


Change in Fiscal Year End and Reporting Periods

In December 2004, the Company changed its fiscal year from one ending on December 31 to one ending on June 30. Application for the change in accounting year is pending with the Internal Revenue Service. Accordingly, the Company’s transition period that ended on December 31, 2004, includes the six months ended December 31, 2004 (“Transition 2004”) and incorporates the operating results of EMC for that period (as opposed to since EMC’s acquisition on October 7, 2004).

The following are selected financial data for Transition 2004 and the comparable six-month period of the prior year:


   
ILNP
 
EMC
 
Combined
   
December 30, 2004
 
December 30, 2004
 
December 30, 2004
   
(Six months)
(as adjusted)
 
(Six months)
(as adjusted
 
(Six months)
(as adjusted)
Net sales
$ -
 
$ 2,289,728
 
$ 2,289,728
Cost of goods sold
-
 
1,873,385
 
1,873,385
 
Gross profit
$ -
 
$ 416,343
 
$ 416,343
Selling and administrative expenses
$ 119,867
 
$ 145,613
 
$ 265,480
Salaries and contract labor
33,228
 
146,028
 
179,256
Depreciation and amortization
-
 
4,056
 
4,056
Legal and professional
936,898
 
85,781
 
1,022,679
 
Total expenses
$ 1,089,993
 
$ 381,478
 
$ 1,471,471
Net (loss) from operations
$ (1,089,993)
 
$ 34,865
 
$ (1,055,128)
Interest expense
$ 117,909
 
$ 80,047
 
$ 197,956
 
Income before income taxes
 
 
 
 
 
 
and discontinued operations
$ (1,207,902)
 
$ (45,182)
 
$ (1,253,084)
Gain on discontinued operations
$ -
 
$ -
 
$ -
 
Income before income taxes
$ (1,207,902)
 
$ (45,182)
 
$ (1,253,084)
Income tax expense
$ -
 
$ (18,073)
 
$ (18,073)
 
Net income
$ (1,207,902)
 
$ (27,109)
 
$ (1,235,011)


The following is the pro-forma operating results for the six months ended December 31, 2003 assuming EMC had been included in the operating results of the Company during that period.

   
ILNP
 
EMC
 
Combined
   
December 30, 2003
 
December 30, 2003
 
December 30, 2003
   
(Six months)
(as adjusted)
 
(Six months)
(as adjusted)
 
(Six months)
(as adjusted)
Net sales
$ 86,320
 
$ 1,684,267
 
$ 1,770,587
Cost of goods sold
-
 
1,288,120
 
1,288,120
 
Gross profit
$ 86,320
 
$ 396,147
 
$ 482,467
Selling and administrative expenses
$ 95,855
 
$ 165,862
 
$ 261,717
Salaries and contract labor
1,416,885
 
133,800
 
1,550,685
Depreciation and amortization
46,637
 
5,516
 
52,153
Legal and professional
111,418
 
138,000
 
249,418
 
Total expenses
$ 1,670,795
 
$ 443,178
 
$ 2,113,973
Net (loss) from operations
$ (1,584,475)
 
$ (47,031)
 
$ (1,631,506)
Interest expense
$ 122,097
 
$ 63,458
 
$ 185,555
 
Income before income taxes
 
 
 
 
 
 
and discontinued operations
$ (1,706,572)
 
$ (110,489)
 
$ (1,817,061)
Gain on discontinued operations
$ -
 
$ -
 
$ -
 
Income before income taxes
$ (1,706,572)
 
$ (110,489)
 
$ (1,817,061)
Income tax expense
$ -
 
$ (44,195)
 
$ (44,195)
 
Net income
$ (1,706,572)
 
$ (66,294)
 
$ (1,772,866)


Results of operations for the interim periods are not indicative of annual results.

4


Results of Operations:

For the Three Months ended December 31, 2004 and 2003

Revenue and gross profit for the three months ended December 31, 2004 was $1,348,787 and $222,282, respectively, and reflects the revenue and gross profit derived from EMC’s operations since acquisition on October 7, 2004. The miscellaneous revenue and gross profit of $60,921 for the same period in the prior year represented residual income from the bio tech division sold in May 2004 to Power 3.

Total operating expenses for the three-month period ended December 31, 2004 was $1,232,949. Of this amount, $206,268 was due to EMC’s operations and the balance, or $1,026,681, was due to ILNP corporate. The greater majority of these corporate expenses pertained to legal and professional fees of $942,218, arising from the acquisition of EMC and the reorganization of the Company. The operating expenses in the same three-month period in the prior year were $455,079. Salary and contract labor accounted for $387,791 of this total. Interest expenses for the three months ended December 31, 2004 and 2003 was $110,732 and $67,848, respectively. Interest expense in the three months ended December 31, 2004 pertaining to the EMC operation was $43,781.

The result of the above was a net loss for the three months ended December 31, 2004 of $(1,109,060), compared to a loss of $(462,005) in the same period in 2003.

For the Six Months ended December 31, 2004 and 2003

Revenue and gross profit for the six months ended December 31, 2004 was $1,348,787 and $222,282, respectively, and reflects the revenue and gross profit derived from EMC’s operations since the acquisition on October 7, 2004. The miscellaneous revenue and gross profit of $86,320 for the same period in the prior year represented residual income from the bio tech division sold in May 2004 to Power 3.

Total operating expenses for the three-month period ended December 31, 2004 was $1,299,260. Of this amount, $206,268 was due to EMC’s operations and the balance, or $1,092,992, was due to ILNP corporate. The greater majority of these corporate expenses pertained to legal and professional fees of $ 979,679, arising from the acquisition of EMC and the reorganization of the Company. The operating expenses in the same six-month period in the prior year were $1,670,795. Salary and contract labor accounted for $1,416,885 of this total. Included in the six month amounts in 2003 was a current period expense of $660,000 for the stock grant of 825,000 shares (at $0.80 per share) to the former CEO of the Company. In addition, an additional 200,000 shares (at $0.80 per share) was promised under an option agreement entered into on September 5, 2003 but not yet executed; nor are they anticipated to be executed since the officer is no longer employed by the Company.

Interest expenses for the six months ended December 31, 2004 and 2003 was $161,195 and $122,097 respectively. Interest expense in the six month ended December 31, 2004 pertaining to the EMC operation was $43,781.
5



The result of the above was a net loss for the six months ended December 31, 2004 of $(1,225,835) compared to a loss of $(1,706,572) in the same period in 2003.

Net (loss) income per share basic and diluted for the three and six months ended December 31, 2004 was $(0.06) and $(0.07) per share, respectively, compared to $(0.04) and $(0.15) in the same respective periods in 2003.


Liquidity and Capital Resources:

The Company had a working capital deficit of $(1,791,248) as at December 31, 2004. This compares to a working capital deficit of $(1,977,216) as at December 31, 2003.

Net cash provided by operations for the six months ended December 31, 2004 was a negative $(887,952), compared to a negative cash flow in the same period in 2003 of $(443,275). The majority of the increase is attributable to the decrease in losses for the comparable periods offset by the non cash requirement generated from stock based compensation in the 2003 period.

The Company obtained funds to operate in the six months ended December 31, 2004 from the issuance of common stock subscriptions in the amount of $315,000 and increased notes payable and bank debt of approximately $600,000.

CAUTIONARY STATEMENT FOR PURPOSES OF THE "SAFE HARBOR" PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

It should be noted that in this Management's Discussion and Analysis or Plan of Operations contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The terms "believe", "anticipate", "intend", "goal", "expect" and similar expressions may identify forward-looking statements. These forward-looking statements represent the Company's current expectations or beliefs concerning future events. The matters covered by these statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements, including, but not limited to: (i) the Company's history of ongoing operating losses; (ii) the overall marketplace and clients' usage of EMC’s products, including demand therefor, the impact of competitive technologies, products and pricing, particularly given the substantially larger size and scale of certain competitors and potential competitors, control of expenses, and revenue generation by the acquisition of new customers; (iii) the consequent results of operations given the aforementioned factors; and (iv) the requirement for the Company to raise additional working capital to fund operations and the availability and terms of any such funding to the Company. Without any such funding, the Company believes it may be forced to curtail operations, and if no alternative to financing, such as a merger or acquisition, is consummated, the Company may not continue as a going concern. Other risks are detailed from time to time in the Company's 2003 Annual Report on Form 10-K, as amended, and in its other Securities and Exchange Commission reports and statements. The foregoing list should not be construed as exhaustive, and the Company disclaims any obligation to subsequently revise any forward-looking statements to reflect events or circumstances after the date of such statements, or to reflect the occurrence of anticipated or unanticipated events. The Company wishes to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made.


6



Item 3. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

The Company's Chief Executive Officer and Chief Financial Officer, after evaluating the effectiveness of the Company's disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e)) as of the end of the period being reported (the "Evaluation Date"), have concluded that as of the Evaluation Date, the Company's disclosure controls and procedures were not effective in ensuring that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission's rules and forms. Such officers reached this conclusion because the Company’s records, prior to the recent change in management, had not been maintained and processed to meet both financial reporting and other Commission disclosure needs and requirements. Management has reviewed the recommendations set forth in a letter from the Company’s auditors and have set March 30, 2005 as a deadline to bring the Company’s disclosure controls and procedures in line with such recommendations. The Company’s independent auditors have made a number of recommendations including, but not limited to, the following: (i) the Company should improve accounting controls through the formalization of accounting practices through promulgation of accounting policies and procedures, and (ii) additional recommendations related to improving internal controls through the separation of duties within the accounting function. Management has hired outside consultants to help with this process.

Changes in Internal Controls

No significant changes in the Company's internal controls or in other factors that could significantly affect these controls following the Evaluation Date came to management's attention.


PART II

Item 1. Legal Proceedings.

As of March 30, 2005, the Company was neither a party nor was any of its properties subject to any legal proceedings.


7
 



Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

The following sets forth information relating to all sales of our common stock during the quarter ended December 31, 2004, which sales were not registered under the Securities Act.

During the quarter ended December 31, 2004, had no sales of shares of its common stock. Shares of common stock were subscribed to during the quarter but were not issued.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Submission of Matters to a Vote of Security Holders.

None.

Item 5. Other Information.

Please see “Recent Developments” on page 1.

Item 6. Exhibits.

Exhibit Index

31.1
Certification of the Principal Executive Officer pursuant to Rule 13a-14(a).
31.2
Certification of the Principal Financial Officer pursuant to Rule 13a-14(a).
32.1
Section 1350 Certification of the Chief Executive Officer.
32.2
Section 1350 Certification of the Chief Financial Officer.


8


Signatures

In accordance with the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Industrial Enterprises of America, Inc.
(Registrant)

Date: March 31, 2005
By: /s/ John D. Mazzuto        
John D. Mazzuto
Chief Financial Officer, Vice Chairman of the Board, Assistant Secretary and a Director



Date: March 31, 2005
By:  /s/ Crawford Shaw        
Crawford Shaw
Chief Executive Officer, Chairman of the Board, President and a Director

Date: March 31, 2005
By: /s/ Dennis O’Neill        
Dennis O’Neill
Controller



INDUSTRIAL ENTERPRISES OF AMERICA, INC.
Balance Sheet
December 31, 2004
(Unaudited)


ASSETS
       
 
Current Assets
   
   
Cash
   
$ 10,900
   
Accounts receivable
929,330
   
Inventory
 
655,913
   
Prepaid expenses
13,632
 
Total Current Assets
$ 1,609,775
 
Investment in common stock
145,725
 
Property, plant and equipment net of accumulated depreciation
100,043
 
Other Assets
 
100,000
 
Goodwill
   
418,029
TOTAL ASSETS
   
$ 2,373,572

F - 1
See Notes to Financials

 


 
LIABILITIES & SHAREHOLDERS' DEFICIT
 
Current Liabilities
   
Litigation settlement payable
$ 20,000
   
Current maturities of long term debt
157,916
   
Liabilities due to discontinued operations
211,753
   
Credit card debt - related parties
92,663
   
Bank line of credit
831,761
   
Accounts payable
747,740
   
Other accrued payables
599,704
   
Accrued salaries, benefits and severance pay
153,032
   
Accrued interest
370,154
   
Accrued interest to shareholders and related parties
111,739
   
Related party payable
76,832
   
Lease payables
22,906
   
Contractor payable
4,823
   
Total Current Liabilities
$ 3,401,023
 
Long Term Liabilities
 
 
   
Notes payable, net of current maturities
1,080,572
   
Notes payable related parties and shareholders
388,115
   
Other debt
53,740
   
Deferred taxes
92,099
   
Total Long Term Liabilities
$ 1,614,526
 
Total Liabilities
$ 5,015,549
 
Shareholders' Deficit
 
   
Common stock, $0.001 par value,
 
     
50,000,000 shares authorized,
 
     
18,577,750 shares issued and outstanding
 
     
at December 31, 2004
18,578
   
Additional paid-in capital
2,007,687
   
Subscribed stock
1,123,474
   
Treasury stock
(45,002)
   
Retained (deficit)
(5,746,714)
 
Total Shareholders' Deficit
$ (2,641,977)
TOTAL LIABILITIES & SHAREHOLDERS' DEFICIT
$ 2,373,572

F - 2
See Notes to Financials

 
INDUSTRIAL ENTERPRISES OF AMERICA, INC.
Statement of Operations
(Unaudited)


     
Three Months Ended
 
Six Months Ended
     
December 31, 2004
 
December 31, 2003
(as adjusted)
 
December 31, 2004
 
December 31, 2003
(as adjusted)
                   
Revenues
$ 1,348,787
 
$ 60,921
 
$ 1,348,787
 
$ 86,320
                   
Cost of Goods Sold
1,126,505
 
-
 
1,126,505
 
-
                   
Gross Profit
$ 222,282
 
$ 60,921
 
$ 222,282
 
$ 86,320
                   
Expenses:
             
 
Selling, general & administrative
$ 171,986
 
$ 16,048
 
$ 196,108
 
$ 95,855
 
Salaries and contract labor
112,774
 
387,791
 
117,502
 
1,416,885
 
Depreciation and amortization
5,971
 
23,319
 
5,971
 
46,637
 
Legal and professional fees
942,218
 
27,921
 
979,679
 
111,418
 
Total Expenses
$ 1,232,949
 
$ 455,079.00
 
$ 1,299,260.00
 
$ 1,670,795
 
(Loss) from operations
$ (1,010,667)
 
$ (394,157)
 
$ (1,076,978.)
 
$ (1,584,475)
                   
Interest expense
110,732
 
67,848
 
161,195
 
122,097
Net (Loss) from operations
$ (1,121,398)
 
$ (462,005.)
 
$ (1,238,173.)
 
$ (1,706,572)
                   
Miscellaneous income
3,000
 
-
 
3,000
 
-
Provision for income taxes
9,338
 
-
 
9,338
 
-
                   
Net income (loss)
$ (1,109,060)
 
$ (462,005)
 
$ (1,225,835)
 
$ (1,706,572)
                   
                   
Net income (loss) per share basic and diluted
$ (0.06)
 
$ (0.04)
 
$ (0.07)
 
$ (0.15)
                   
Weighted average number of common shares outstanding
18,577,750
 
11,111,338
 
18,577,750
 
11,111,338



F - 3
See Notes to Financials

 
 
INDUSTRIAL ENTERPRISES OF AMERICA, INC.
Statement of Cash Flows
(Unaudited)

       
Six Months Ended
       
December 31, 2004
 
December 31, 2003
(as adjusted)
             
Operating activities
     
 
Net income (loss)
$ (1,225,835)
 
$ (1,706,888)
 
Non-cash items
     
   
Depreciation and amortization
5,971
 
46,636
   
Stock based compensation
   
734,206
 
Net changes in working capital accounts
331,912
 
482,771
 
Net cash (used) by operating activities
$ (887,952)
 
$ (443,275)
Investing activities
     
 
Additions to property, plant and equipment
(5,264)
 
-
 
Other
 
(1,013)
 
-
 
Net cash (used) by investing activities
$ (6,277)
 
$ -
Financing activities
     
 
Bank overdraft
-
 
7,498
 
Bank line of credit
111,848
 
6,642
 
Notes payable
488,729
 
58,307
 
Notes payable related party and shareholders
(138,729)
 
(1,856)
 
Other debt
(58,412)
 
-
 
Common stock issued
98,475
 
317,000
 
Stock subscriptions
315,000
 
(12,487)
 
Treasury stock
(45,001)
 
-
 
Net cash provided by Financing Activities
$ 771,910
 
$ 375,104
Net cash increase for period
$ (122,319)
 
$ (68,171)
Cash at beginning of period
133,219
 
68,171
Cash at end of period
$ 10,900
 
$ 0


F - 4
See Notes to Financials

 
Note 1 - Basis of presentation

Effective February 11, 2005, the Company changed its name to Industrial Enterprises of America, Inc. from Advanced Bio/Chem, Inc.

The Company has suffered recurring losses from operations and its total liabilities exceed its total assets. This raises substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Effective April, 2003, the Company elected to file as a non-reporting entity in accordance with Rule 12g-4 of the Securities Exchange Act of 1934. The Company has currently elected to reinstate as a filing entity and, as such, reference to year-end financial statements should be referred to the Company’s Form 10-KSB for the fiscal year ended December 31, 2003.

The condensed financial statements included herein have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures are adequate to make the information presented not misleading.

These statements reflect all adjustments, consisting of normal recurring adjustments, which, in the opinion of management, are necessary for fair presentation of the information contained therein. It is recommended that these condensed financial statements be read in conjunction with the financial statements and notes thereto included in the Company’s 2003 Form 10-KSB.

During 2004, the Company changed its fiscal year from one ending on December 31 to one ending on June 30. Application for the change in accounting year is pending with the Internal Revenue Service. Accordingly, the Company’s transition period that ended on December 31, 2004, includes the six months ended December 31, 2004 (Transition 2004). The following are selected financial data for Transition 2004 and the comparable six-month period of the prior year:

   
ILNP
 
EMC
 
Combined
   
December 30, 2004
 
December 30, 2004
 
December 30, 2004
   
(Six months)
 
(Six months)
(as adjusted)
 
(Six months)
(as adjusted)
Net sales
$ -
 
$ 2,289,728
 
$ 2,289,728
Cost of goods sold
-
 
1,873,385
 
1,873,385
 
Gross profit
$ -
 
$ 416,343
 
$ 416,343
Selling and administrative expenses
$ 119,867
 
$ 145,613
 
$ 265,480
Salaries and contract labor
33,228
 
146,028
 
179,256
Depreciation and amortization
-
 
4,056
 
4,056
Legal and professional
936,898
 
85,781
 
1,022,679
 
Total expenses
$ 1,089,993
 
$ 381,478
 
$ 1,471,471
Net (loss) from operations
$ (1,089,993)
 
$ 34,865
 
$ (1,055,128)
Interest expense
$ 117,909
 
$ 80,047
 
$ 197,956
 
Income before income taxes
 
 
 
 
 
 
and discontinued operations
$ (1,207,902)
 
$ (45,182)
 
$ (1,253,084)
Gain on discontinued operations
$ -
 
$ -
 
$ -
 
Income before income taxes
$ (1,207,902)
 
$ (45,182)
 
$ (1,253,084)
Income tax expense
$ -
 
$ (18,073)
 
$ (18,073)
 
Net income
$ (1,207,902)
 
$ (27,109)
 
$ (1,235,011)


F - 5
 

 

   
ILNP
 
EMC
 
Combined
   
December 30, 2003
 
December 30, 2003
 
December 30, 2003
   
(Six months)
 
(Six months)
(as adjusted)
 
(Six months)
(as adjusted)
Net sales
$ 86,320
 
$ 1,684,267
 
$ 1,770,587
Cost of goods sold
-
 
1,288,120
 
1,288,120
 
Gross profit
$ 86,320
 
$ 396,147
 
$ 482,467
Selling and administrative expenses
$ 95,855
 
$ 165,862
 
$ 261,717
Salaries and contract labor
1,416,885
 
133,800
 
1,550,685
Depreciation and amortization
46,637
 
5,516
 
52,153
Legal and professional
111,418
 
138,000
 
249,418
 
Total expenses
$ 1,670,795
 
$ 443,178
 
$ 2,113,973
Net (loss) from operations
$ (1,584,475)
 
$ (47,031)
 
$ (1,631,506)
Interest expense
$ 122,097
 
$ 63,458
 
$ 185,555
 
Income before income taxes
 
 
 
 
 
 
and discontinued operations
$ (1,706,572)
 
$ (110,489)
 
$ (1,817,061)
Gain on discontinued operations
$ -
 
$ -
 
$ -
 
Income before income taxes
$ (1,706,572)
 
$ (110,489)
 
$ (1,817,061)
Income tax expense
$ -
 
$ (44,195)
 
$ (44,195)
 
Net income
$ (1,706,572)
 
$ (66,294)
 
$ (1,772,866)

Results of operations for the interim periods are not indicative of annual results.

Note 2 - Earnings per share

Basic earnings per share (EPS) includes dilution and is determined by dividing income available to common stockholders by the weighted average number of shares of common stock outstanding. Diluted EPS reflects the potential dilution that could occur if options and other contracts to issue shares of common stock were exercised or converted into common stock. There are warrants to issue an additional 2,600,000 shares as of December 31, 2004, and no warrants or options as of December 31, 2003. None of the warrants have been exercised as of December 31, 2004.

Note 3 - Stock based compensation

As permitted under generally accepted accounting principles, stock-based awards granted to employees are accounted for following APB 25. Accordingly, the Company has not recognized compensation expense for its stock-based awards to employees. Outlined below are pro forma results had compensation costs for the Company’s stock-based compensation plans been determined based on the fair value approach of SFAS 123.
For the Three Months Ended
December 31 
 
2004
 
2003
(as adjusted)
Net income (loss), as reported
$(1,109,060)
 
$(464,677)
Less compensation cost determined under the fair value method
-
 
-
Pro forma net income (loss)
$(1,109,060)
 
$(464,677)

Basic and dilutive (loss) per share:
     
As reported
$ (0.06)
 
$ (0.04)
Pro forma
$ (0.06)
 
$ (0.04)
       


F - 6

 
For the Six Months Ended
December 31
 
2004
 
2003
(as adjusted)
Net income (loss), as reported
$(1,225,835)
 
$(1,706,571)
Less compensation cost determined under the fair value method
-
 
-
Pro forma net (loss)
$(1,225,835)
 
$(1,706,571)

Basic and dilutive (loss) per share:
     
As reported
$ (0.07)
 
$ (0.15)
Pro forma
$ (0.07)
 
$ (0.15)

These pro forma amounts may not be representative of future disclosures since the estimated fair value of stock options is amortized to expense over the vesting period and options may be granted in future years.

Steven Rash, former CEO, was granted 825,000 shares of common stock at $0.80 per share for a charge of $660,000 against operations for the quarter ended September 30, 2003. In addition, pursuant to Mr. Rash’s September 5, 2003, employment contract, an option agreement for an additional 200,000 shares at the exercise price of $0.80 was promised, but as yet not executed. No charge to current operations has been made for the unexecuted option. These options are not anticipated to be executed.

Disclosures required by Statement of Financial Accounting Standards No. 123, "Accounting for Stock-Based Compensation" ("SFAS No. 123"), including pro forma operating results had the Company prepared its financial statements in accordance with the fair value based method of accounting for stock- based compensation prescribed therein are shown below. Exercise prices and weighted-average contractual lives of stock options outstanding as of December 31, 2004 are as follows:

Options Outstanding
 
Options Exercisable
       
Weighted Average
 
Weighted Average
     
Weighted Average
Exercise Prices
 
Number Outstanding
 
Remaining Contractual Life
 
Exercise Prices
 
Number Exercisable
 
Exercise Price
$0.50
 
2,600,000
 
4.25
 
$0.50
 
2,600,000
 
$0.50

Summary of Options Granted and Outstanding:

   
For the six months ended December 31
   
2004
 
2003
(as adjusted)
   
Shares
 
Weighted Average Exercise Price
 
Shares
 
Weighted Average Exercise Price
Options:
               
Outstanding at beginning of period
 
-
 
$ -
 
-
 
$ -
Granted
 
2,600,000
 
$ 0.50
 
-
 
$ -
Cancelled
 
-
 
$ -
 
-
 
$ -
Outstanding at end of period
 
2,600,000
 
$ 0.50
 
-
 
$ -

F - 7

 

The following table summarizes the pro forma operating results of the Company for December 31, 2004, had compensation costs for the stock options granted to employees been determined in accordance with the fair value based method of accounting for stock based compensation as prescribed by SFAS No. 123.

Proforma net income (loss) available to common stockholders  $ (1,225,835)

Proforma basic and diluted loss per share    $ (0.07)

Note 4 - Line of credit with bank

The Company has a $150,000 renewable line of credit with a commercial bank. The line bears interest at the bank’s prime rate plus 1%. There was an outstanding balance as of December 31, 2004, of $150,957. The line is guaranteed by the personal guarantees of certain shareholders and contains certain financial covenants.

The Company recorded interest expense totaling $161,195 and $122,097 for the six months ended December 31, 2004 and 2003, respectively.

Note 5 - Changes in outstanding shares of common stock

Included in the table below are the changes in shares of common stock since December 31, 2003. See Note 7 for discussion of mergers and acquisitions affecting shares of common stock.

 
Common
 
Stock
Outstanding shares of common stock at December 31, 2003
11,111,338
Stock granted to employees
500,000
Debt converted to stock
152,746
Stock issued for cash
1,813,666
Stock issued for services
5,000,000
Outstanding shares of common stock at December 31, 2004
18,577,750

Note 6 - Discontinued operations

On May 11, 2004, by unanimous consent of the Board of Directors and a majority of the stockholders of the Company, the Company entered into an Asset Purchase Agreement with Power 3 Medical Products, Inc., a New York corporation (“Power 3”). Effective May 18, 2004, the purchase agreement was finalized and the assets and certain liabilities were acquired by Power 3 for 15,000,000 shares of common stock of Power 3. (See Note 7 - Mergers and acquisitions for further details.)

The assets and liabilities of the Company as of May 17, 2004 consisted of the following:

Cash
$ 3,796
Accounts receivable - trade
5,785
Equipment, net of accumulated depreciation
128,881
Patents, net of accumulated amortization
16,844
Leasehold security deposit
2,968
 
 
Total Assets
$ 158,274
   
Capital leases
147,639
Accounts payable
80,437
Accrued expenses
31,675
 
 
Total Liabilities Disposed of
$ 259,751
 
 
Liabilities due to discontinued operations
$(101,477)

F - 8

 

The operating results of this discontinued operation for the period ended May 17, 2004, consisted of the following:
 
Revenues
$ 141,362
Operating expenses
(355,974)
Interest expense
( 58,221)
   
Net (loss)
$(272,884)

Note 7 - Mergers and acquisitions

On May 5, 2003, the Company and GESJ, Inc. (“GESJ”), a Texas corporation, owned by four officers of the Company, entered into an agreement and plan of merger in which GESJ merged into the Company in a tax-free exchange of shares. 1,903,000 shares of common stock of the Company were exchanged for all the issued and outstanding shares of GESJ. The Company continued as the surviving entity. The purpose of the merger was to acquire the management team of GESJ. GESJ had no assets or liabilities as of the merger date. The Company has not recorded the transaction as stock issued for compensation to the officers involved due to the cancellation of the shares.

As previously disclosed, on June 12, 2003, the Company’s directors approved a merger with Ciro International, Inc. (“Ciro”), a Nevada Corporation, whereby the Company would be the surviving entity in a reverse acquisition with Ciro, a public shell company. For accounting purposes, the combination was treated as an issuance of shares for cash by the Company and has not been considered a business combination.

On May 18, 2004, all fixed assets and intellectual property were acquired by Power 3 for 15,000,000 restricted shares of Power 3 common stock, plus employment of certain of the Company’s employees, and assumption of certain liabilities of the Company. The transaction is recognized as a related party transaction and was recorded as an exchange of assets at the book value of the fixed and intellectual properties for the restricted shares.

On October 7, 2004, the Company’s Board of Directors approved a merger with EMC Packaging, Inc., a Delaware corporation (“EMC”). In consideration for the shares of EMC common stock, the EMC stockholders received an aggregate of 2,296,800 shares of the Company’s common stock, valued at $808,474. For accounting purposes, the merger has been considered a business combination.
 
F - 9